QuickView for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=C367D95CAF574A9239FE4295078310FA;jsessionid=ED732D6F8E2B55D44E4470C64FCAE073;jsessionid=369D0FFBC2D87636BB1B0994D6332FBD;jsessionid=86EE8D8B6B703E6EEBA3A5B918311149;jsessionid=A1D74522D49F2A4AF54A4022A38D48B1;jsessionid=06E70D9D79CEB3A7B96E4A0AECE677FA;jsessionid=9B53035745DA38ECB11D0925A3B55AD5;jsessionid=0FAF16F4754B383F952EF2AA927F4500;jsessionid=F8DDC09A341E5011CCD6A38271410056;jsessionid=894A0C3B57F9B5D8ADF946B43C21D6A2;jsessionid=CC2D9F0B3E9EF8A5059B8AA3B27F713D;jsessionid=5714ACC3D00F0470B53E54A6E4B8A17D;jsessionid=BD1F76DE683E47A4AB5DDAEB71B6C036 (gene)

1. Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
2. Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
3. Stability of varicella-zoster virus open reading frame 63.
4. Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
5. Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…

There were no clinical trials for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=C367D95CAF574A9239FE4295078310FA;jsessionid=ED732D6F8E2B55D44E4470C64FCAE073;jsessionid=369D0FFBC2D87636BB1B0994D6332FBD;jsessionid=86EE8D8B6B703E6EEBA3A5B918311149;jsessionid=A1D74522D49F2A4AF54A4022A38D48B1;jsessionid=06E70D9D79CEB3A7B96E4A0AECE677FA;jsessionid=9B53035745DA38ECB11D0925A3B55AD5;jsessionid=0FAF16F4754B383F952EF2AA927F4500;jsessionid=F8DDC09A341E5011CCD6A38271410056;jsessionid=894A0C3B57F9B5D8ADF946B43C21D6A2;jsessionid=CC2D9F0B3E9EF8A5059B8AA3B27F713D;jsessionid=5714ACC3D00F0470B53E54A6E4B8A17D;jsessionid=BD1F76DE683E47A4AB5DDAEB71B6C036